Explore
Validate
LearnABIN967155
antibody from antibodies-online
Targeting: MAPT
DDPAC, FLJ31424, FTDP-17, MAPTL, MGC138549, MSTD, MTBT1, MTBT2, PPND, PPP1R103, tau
ImmunohistochemistryAntibody data
- Antibody Data
- Antigen structure
- References [3]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- ABIN967155 - Provider product page
- Provider
- antibodies-online
- Product name
- anti-Microtubule-Associated Protein tau (MAPT) antibody
- Antibody type
- Polyclonal
- Antigen
- The antiserum was produced against synthesized non-phosphopeptide derived from human Tau around the phosphorylation site of serine 235 (P-K-SP-P-S).
- Description
- The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
- Reactivity
- Human, Mouse, Rat
- Host
- Rabbit
- Vial size
- 100 μg
- Concentration
- 100ug/100ul.
- Storage
- -20°C
Submitted references Promotion of hyperphosphorylation by frontotemporal dementia tau mutations.
Involvement of aberrant glycosylation in phosphorylation of tau by cdk5 and GSK-3beta.
Phosphorylation of tau at both Thr 231 and Ser 262 is required for maximal inhibition of its binding to microtubules.
Alonso Adel C, Mederlyova A, Novak M, Grundke-Iqbal I, Iqbal K
The Journal of biological chemistry 2004 Aug 13;279(33):34873-81
The Journal of biological chemistry 2004 Aug 13;279(33):34873-81
Involvement of aberrant glycosylation in phosphorylation of tau by cdk5 and GSK-3beta.
Liu F, Iqbal K, Grundke-Iqbal I, Gong CX
FEBS letters 2002 Oct 23;530(1-3):209-14
FEBS letters 2002 Oct 23;530(1-3):209-14
Phosphorylation of tau at both Thr 231 and Ser 262 is required for maximal inhibition of its binding to microtubules.
Sengupta A, Kabat J, Novak M, Wu Q, Grundke-Iqbal I, Iqbal K
Archives of biochemistry and biophysics 1998 Sep 15;357(2):299-309
Archives of biochemistry and biophysics 1998 Sep 15;357(2):299-309
No comments: Submit comment
No validations: Submit validation data